Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Munksgaard

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Ejhaem|December 18, 2024
Extramedullary disease in Waldenström macroglobulinemia: A population-based observational studySimon Østergaard, Lars Munksgaard, Torsten Holm Nielsen, et al.
Journal of Hematology|January 12, 2023
Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort StudyKhazra Bhatti, Aqsa Nazir, Simon Ostergaard, et al.
Blood|April 22, 2008
Borrelia infection and risk of non-Hodgkin lymphomaClaudia Schöllkopf, Mads Melbye, Lars Munksgaard, et al.
Leukemia & Lymphoma|February 10, 2024
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practiceSimon Østergaard, Lone Schejbel, Marie Fredslund Breinholt, et al.
Journal of the National Cancer Institute|January 18, 2007
Atopy and risk of non-Hodgkin lymphomaMads Melbye, Karin Ekström Smedby, Tuula Lehtinen, et al.
Haematologica|December 31, 2011
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costsTarec Christoffer El-Galaly, Karen Juul Mylam, Peter Brown, et al.
Oncoimmunology|January 9, 2018
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapyShamaila Munir Ahmad, Evelina Martinenaite, Morten Holmström, et al.
Leukemia & Lymphoma|October 23, 2013
Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphomaKaren J Mylam, Tarec C El-Galaly, Martin Hutchings, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Leukemia & Lymphoma|April 19, 2022
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort studyMaja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Ejhaem|December 18, 2024
Extramedullary disease in Waldenström macroglobulinemia: A population-based observational studySimon Østergaard, Lars Munksgaard, Torsten Holm Nielsen, et al.
Journal of Hematology|January 12, 2023
Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort StudyKhazra Bhatti, Aqsa Nazir, Simon Ostergaard, et al.
Blood|April 22, 2008
Borrelia infection and risk of non-Hodgkin lymphomaClaudia Schöllkopf, Mads Melbye, Lars Munksgaard, et al.
Leukemia & Lymphoma|February 10, 2024
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practiceSimon Østergaard, Lone Schejbel, Marie Fredslund Breinholt, et al.
Journal of the National Cancer Institute|January 18, 2007
Atopy and risk of non-Hodgkin lymphomaMads Melbye, Karin Ekström Smedby, Tuula Lehtinen, et al.
Haematologica|December 31, 2011
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costsTarec Christoffer El-Galaly, Karen Juul Mylam, Peter Brown, et al.
Oncoimmunology|January 9, 2018
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapyShamaila Munir Ahmad, Evelina Martinenaite, Morten Holmström, et al.
Leukemia & Lymphoma|October 23, 2013
Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphomaKaren J Mylam, Tarec C El-Galaly, Martin Hutchings, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Leukemia & Lymphoma|April 19, 2022
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort studyMaja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, et al.
Pageof 3